This Standard shall be applied by all entities to all types of financial instruments E1 except: (a) those interests in subsidiaries, associates and joint ventures that are accounted for in accordance with IFRS 10 Consolidated Financial Statements , IAS 27 Separate Financial Statements or IAS 28 Investments in Associates and Joint Ventures . [ Refer: IAS 28 paragraph 14A ] [Refer also: IAS 28 Supporting Material (see Part B)—Example published by the Board to accompany Long-term Interests in Associates and Joint Ventures (Amendments to IAS 28) in October 2017 ] However, in some cases, IFRS 10, IAS 27 or IAS 28 require or permit an entity to account for an interest in a subsidiary, associate or joint venture in accordance with some or all of the requirements of this Standard. Entities shall also apply this Standard to derivatives on an interest in a subsidiary, associate or joint venture unless the derivative meets the definition of an equity instrument of the entity in IAS 32 Financial Instruments: Presentation . (b) rights and obligations under leases to which IFRS 16 Leases applies. However: (i) finance lease receivables (ie net investments in finance leases) and operating lease receivables recognised by a lessor are subject to the derecognition and impairment requirements of this Standard; E2 (ii) lease liabilities recognised by a lessee are subject to the derecognition requirements in paragraphs 3.3.1 and 3.3.3 of this Standard; [ Refer: Basis for Conclusions paragraphs BC2.44–BC2.46 ] and (iii) derivatives that are embedded in leases are subject to the embedded derivatives requirements of this Standard. (c) employers’ rights and obligations under employee benefit plans, to which IAS 19 Employee Benefits applies. (d) financial instruments issued by the entity that meet the definition of an equity instrument in IAS 32 (including options and warrants) or that are required to be classified as an equity instrument in accordance with paragraphs 16A and 16B or paragraphs 16C and 16D of IAS 32 . However, the holder of such equity instruments shall apply this Standard to those instruments, unless they meet the exception in (a). (e) rights and obligations arising under an insurance contract as defined in IFRS 17 Insurance Contracts , or an investment contract with discretionary participation features within the scope of IFRS 17. However, this Standard applies to: (i) derivatives that are embedded in contracts within the scope of IFRS 17, if the derivatives are not themselves contracts within the scope of IFRS 17. (ii) investment components that are separated from contracts within the scope of IFRS 17, if IFRS 17 requires such separation, unless the separated investment component is an investment contract with discretionary participation features within the scope of IFRS 17. (iii) an issuer’s rights and obligations under insurance contracts that meet the definition of a financial guarantee contract . However, if an issuer of financial guarantee contracts has previously asserted explicitly that it regards such contracts as insurance contracts and has used accounting that is applicable to insurance contracts, the issuer may elect to apply either this Standard or IFRS 17 to such financial guarantee contracts (see paragraphs B2.5–B2.6 ). The issuer may make that election contract by contract, but the election for each contract is irrevocable. (iv) an entity’s rights and obligations that are financial instruments arising under credit card contracts, or similar contracts that provide credit or payment arrangements, that an entity issues that meet the definition of an insurance contract but which paragraph 7(h) of IFRS 17 excludes from the scope of IFRS 17. However, if, and only if, the insurance coverage is a contractual term of such a financial instrument, the entity shall separate that component and apply IFRS 17 to it (see paragraph 7(h) of IFRS 17). (v) an entity’s rights and obligations that are financial instruments arising under insurance contracts that an entity issues that limit the compensation for insured events to the amount otherwise required to settle the policyholder’s obligation created by the contract, if the entity elects, in accordance with paragraph 8A of IFRS 17, to apply IFRS 9 instead of IFRS 17 to such contracts. [ Refer: Basis for Conclusions paragraphs BCZ2.9–BC2.17 ] (f) any forward contract between an acquirer and a selling shareholder to buy or sell an acquiree that will result in a business combination within the scope of IFRS 3 Business Combinations at a future acquisition date. The term of the forward contract should not exceed a reasonable period normally necessary to obtain any required approvals and to complete the transaction. [ Refer: Basis for Conclusions paragraphs BCZ2.39–BCZ2.43 ] (g) loan commitments other than those loan commitments described in paragraph 2.3 . However, an issuer of loan commitments shall apply the impairment requirements [ Refer: Basis for Conclusions paragraphs BCZ2.2–BC2.8 and BC5.125–BC5.128 ] of this Standard to loan commitments that are not otherwise within the scope of this Standard. Also, all loan commitments are subject to the derecognition requirements of this Standard. (h) financial instruments, contracts and obligations under share-based payment transactions to which IFRS 2 Share-based Payment applies, except for contracts within the scope of paragraphs 2.4–2.7 of this Standard to which this Standard applies. (i) rights to payments to reimburse the entity for expenditure that it is required to make to settle a liability that it recognises as a provision in accordance with IAS 37 Provisions, Contingent Liabilities and Contingent Assets , or for which, in an earlier period, it recognised a provision in accordance with IAS 37. (j) rights and obligations within the scope of IFRS 15 Revenue from Contracts with Customers that are financial instruments, except for those that IFRS 15 specifies are accounted for in accordance with this Standard.
Nuestros especialistas pueden analizar cómo aplica esta disposición a tu situación particular.
Consulta Sin Costo